Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

N- (2-Amino-phenyl)-4-[(4-pyridin-3-yl-pyrimidin-2-ylamino)-methyl] benzamide

EU orphan designation number: EU/3/07/526   
Active ingredient: N- (2-Amino-phenyl)-4-[(4-pyridin-3-yl-pyrimidin-2-ylamino)-methyl] benzamide
Indication: Treatment of acute myeloid leukaemia
Sponsor: ICON Clinical Research Limited
South County Business Park, Leopardstown, Dublin 18 Ireland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
04/02/2008 Orphan designation EMEA/OD/099/07 (2008)450 of 31/01/2008
06/11/2008 Transfer of orphan designation EMEA/OD/099/07/T/01 (2008)6719 of 04/11/2008
27/03/2009 Transfer of orphan designation EMEA/OD/099/07/T/02 (2009)2319 of 25/03/2009
18/11/2015 Change of name and/or address of sponsor
05/02/2018 Transfer of orphan designation EMA/OD/099/07/T/03 (2018)698 of 01/02/2018